A Senate health care committee on Tuesday approved a bill that would increase funding for the H. Lee Moffitt Cancer Center and Research Institute by giving the center a larger share of the state’s cigarette tax collections.
After the resignations of officials at Moffitt Cancer Center because of issues involving work in China, state House Speaker Jose Oliva, R-Miami Lakes, announced Monday the formation of a select committee to probe foreign involvement in taxpayer-funded research.
House Speaker Jose Oliva is calling for further investigation into the Moffitt Cancer Center and its ties to China after the center’s CEO, director and four researchers announced their resignations on Wednesday.
The first human clinical trial is underway at Moffitt Cancer Center with what researchers are calling a "cancer vaccine."
Health News Florida's Daylina Miller spoke with Patricia Lawman, the co-founder of Tampa-based Morphogenesis. The immunotherapy company developed the vaccine, which is injected into cancer patients to help their immune systems identify and destroy tumors.
The Phase I clinical trial for the vaccine, called ImmuneFX, is being tested on patients with severe cutaneous melanoma.
President Barack Obama in his State of the Union address called for renewed vigor in the fight against cancer. Drawing parallels to John F. Kennedy’s goal to place a man on the moon, Obama charged Vice President Joe Biden to lead a national “moonshot” initiative to eliminate the disease responsible for the deaths of almost 600,000 U.S. citizens’ a year.
University Beat takes you to the USF School of Music, where the next generation of classical musicians had the chance to work with members of The Florida Orchestra, including its Music Director, Michael Francis.
To borrow from the old adage about getting to Carnegie Hall, it takes a lot of practice to be a great classical musician.
But to become a great conductor, there’s not too much a would-be maestro can do, according to University of South Florida masters student Brent Douglas.
Extended University Beat report previewing this year's Pint of Science.
Pour me another one, bartender...or is it pour me another one, doctor?
For the next three nights, scientists will take over bars in nine countries and 50 cities, including a trio of sold-out Tampa area locations, to discuss their work with the public over drinks.
"Pint of Science" was created four years ago in the United Kingdom, and brought over to the U.S. last year by USF Health Molecular Pharmacology & Physiology Research Associate Parmvir Bahia and her husband, Moffitt Cancer Center researcher David Basanta.
"Very often, when we think about how are we going to effectively treat somebody, whether it be cancer, cardiovascular disease, or anything neurodegenerative in nature, when we do the clinical research to gather the evidence, if you don’t have enough people from enough varied backgrounds; we can’t automatically transfer knowledge gained in one part of the population onto another part of the population," Sneed said.
But minority populations – specifically the African American and Hispanic and Latino communities – don’t take part in clinical trials at a level that would give researchers the data they need.
Extended University Beat report on the Tampa Innovation Alliance
The 15,000 acre area surrounding the University of South Florida's Tampa campus has been called "the University Area", "University West," and, derisively, "Suitcase City," due to the number of transients.
But no matter what you call the region, which is bounded by Interstate 275 to the west, I-75 to the East, Busch Boulevard to the south and Bearss Avenue to the north, it's home to thousands of residents, hundreds of businesses, and a few dozen of Tampa’s most recognizable organizations and sites.
"The purpose (of the Alliance) is to make this location recognized around the world as the destination for innovation, creative activity, business enterprise," said Alliance Executive Director Mark Sharpe. "It’s to make this place a place you want to live, work and play."
UPDATED 7/8 with University Beat audio report and additional quotes.
According to the U.S. Centers for Disease Control, over half of American girls ages 13 to 17 have received at least one dose of the vaccination to protect against the human papillomavirus (HPV) - and it's a rate that decreases over the needed second and third doses.
But here in Florida, the number of fully protected young women - those who have received all three doses - is only 25 percent, the lowest in the country.